Similar articles

• Warfarin plus aspirin or aspirin alone for patients with giant coronary artery aneurysms secondary to Kawasaki disease?

  Levin M, Burns JC, Gordon JB. Levin M, et al. Cardiology. 2014;129(3):174-7. doi: 10.1159/000366052. Epub 2014 Oct 7. Cardiology. 2014. PMID: 25300244 No abstract available.
• Comment on the paper by Su et al. entitled 'safety and efficacy of warfarin plus aspirin combination therapy for giant coronary artery aneurysm secondary to kawasaki disease: a meta-analysis'.

  Loomba RS. Loomba RS. Cardiology. 2015;130(3):164-5. doi: 10.1159/000369879. Epub 2015 Feb 7. Cardiology. 2015. PMID: 25676566 No abstract available.
• Safety and efficacy of warfarin plus aspirin combination therapy for giant coronary artery aneurysm secondary to Kawasaki disease: a meta-analysis.

  Su D, Wang K, Qin S, Pang Y. Su D, et al. Cardiology. 2014;129(1):55-64. doi: 10.1159/000363732. Epub 2014 Aug 12. Cardiology. 2014. PMID: 25116427 Review.
• [Prevention of thrombosis of coronary aneurysms in patients with a history of Kawasaki disease].

  Suda K, Kudo Y, Sugawara Y, Ishii M, Matsuishi T. Suda K, et al. Nihon Rinsho. 2008 Feb;66(2):355-9. Nihon Rinsho. 2008. PMID: 18265459 Review. Japanese.
• Coronary artery aneurysm in Kawasaki disease: from multimodality imaging.

  Lee CH, Kim U. Lee CH, et al. Coron Artery Dis. 2020 Mar;31(2):193-194. doi: 10.1097/MCA.0000000000000792. Coron Artery Dis. 2020. PMID: 31821196 No abstract available.